Downregulation of SRPK2 in non-small cell lung cancer cells prevented the induction of apoptosis following cisplatin treatment, whereas downregulation of SRPK1 increased apoptosis [22]. The gene discussed is SRPK1; the disease is non-small cell lung carcinoma.